Andrew Lukowiak

Andrew Lukowiak has a strong background in the biotechnology and healthcare industry. Andrew most recently served as the President and Chief Scientific Officer at Talis Biomedical Corporation since August 2023. Prior to that, they held the same position at Epigenomics AG from December 2021 to May 2023. Andrew also has experience as the CEO of Millennium Health from March 2018 to October 2021 and as the COO and CEO of AltheaDx from June 2013 to February 2018. Additionally, they served as the Senior Director of Programs and Assay Development at GenMark Diagnostics from August 2012 to June 2013, the Senior Director of R&D at Hologic from June 2008 to August 2012, and the Associate Vice President at Third Wave Technologies from January 2001 to June 2008.

Andrew Lukowiak completed their Bachelor of Science degree in Biology/Genetics at Penn State University from 1990 to 1994. Following that, they pursued a Ph.D. in Genetics from The University of Georgia, which they completed from 1994 to 2000.